Page 151 - วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 19 ฉบับที่ 2 พฤษภาคม-สิงหาคม 2564

J Thai Trad Alt Med Vol. 19 No. 2 May-Aug 2021 381

ous research results also reported that carbon this study.
monoxide concentrations in exhaled breath

decreased after intervention of smoking ces- Conclusions
[7]
sation program (Kuwalairat P (2015) and Our result indicated that patients with
[11]
Kleebpratoom P (2016) . non-communicable diseases who followed the
As seen from the result, the intervention intervention programme of Thai traditional
of this study showed no statistically significant medicine were more likely to successfully
differences between the experimental and stop smoking (46.30%) than those in the con-

control groups for inducing smoking cessa- trol group (41.70%) who only administered
tion. However this program helped patients to modern medicine and followed the standard
stop smoking at 44.16%. In contrast, without advice from general practitioners and nurses.

any formal treatment intervention, numbers However, there was no statistically significant
of people who successfully quit smoking are difference in the effect of smoking cessation

[19]
estimated each year at less than 1% . The behavior between the two groups after six
result obtained was with accord to the result of months of treatment.
Kuwalairat P, et. al (2015). They found that the This model integrating modern medicine

outcomes of smoking cessation among non- and Thai traditional medicine offers an oppor-
communicable disease patients at community tunity to increase smoking cessation by health

hospitals under the supervision of clinical care services. However, more experiments
pharmacist helped patients to stop smoking are needed to demonstrate the benefit of this
[7]
at 30.70% , Raya P, et al.(2015) reported that integration programme.
the effects of smoking cessation program
which applying the Transtheoretical model Research limitations
[10]
helped patients to stop smoking at 37.50% This research only studied a specific
and Chaijandee P, et al. (2016) presented that group of patients with non-communicable
the clinical outcome of pharmaceutical care diseases. The intervention programmed was
for smoking cessation helped patients to adapted from previous programmed used for

[16]
stop smoking at 43.06% . All the mentioned patients suffering from other diseases in the
study results revealed that the application of contexts of different hospitals or health care

pharmaceutical care in addition to medication providers.
could lead to a good clinical outcome for the
smoking cessation; the same as was found in